News
MicroPort® Enrolls First Patient in PROMISE-BIF Study to Investigate the Rapamycin Coronary Balloon Catheter for the Treatment of De Novo Coronary Artery Bifurcation Lesions - 12 Mar 2022
MicroPort® has announced the enrollment of the first patient in its PR...CardioFlow Medtech Gets Approval for Alwide® Plus Balloon Catheter - 10 Mar 2022
CardioFlow Medtech recently announced that their Alwide® Plus Balloon ...First Clinical Implantation of Endovastec™’s Hercules®-LP Thoracic Stent Graft System Completed in India - 06 Mar 2022
Endovastec™ has completed the first clinical implantation of its indep...MicroPort® Urocare Obtains NMPA Marketing Approval for Ruyi Clip - 06 Mar 2022
MicroPort® Urocare has received marketing approval from China’s NMPA f...NeuroTech™ NUMEN® Listed for Reimbursement under Korea’s Insurance - 04 Mar 2022
MicroPort NeuroTech™ announced that NUMEN® Coil Embolization System ha...CardioFlow Medtech Launches Multicenter Study on VitaFlow Liberty™ - 28 Feb 2022
CardioFlow Medtech has recently launched a prospective multicenter pos...Firehawk®, Foxtrot® NC & Foxtrot® Pro PTCA Balloon Catheters Get Approval - 25 Feb 2022
MicroPort® has recently received registration approval from the Kyrgyz...Firehawk Liberty™ Receives Registration Approval in Egypt - 23 Feb 2022
Firehawk Liberty™ recently received registration approval from the Cen...MicroPort® MedBot® Announces Inclusion in Hang Seng Composite Index - 22 Feb 2022
MicroPort® MedBot® has announced the company has been selected for inc...NeuroTech™ NUMEN® Listed for Reimbursement under Korea’s Insurance - 22 Feb 2022
MicroPort NeuroTech™ has recently received marketing approval from Chi...MicroPort® Holds Singapore LIVE 2022 Satellite Session on Complex Lesions - 10 Feb 2022
Singapore LIVE 2022, an Asian academic conference in the field of card...MicroPort NeuroTech™ Receives NMPA Marketing Approval for its NUMEN Silk® 3-D Coil Embolization System - 09 Feb 2022
MicroPort NeuroTech™ has received marketing approval from China’s Nati...MicroPort® Toumai® Surgical Robot Receives NMPA Approval, Becoming the First Commercialized Four-Arm Laparoscopic Surgical Robot Developed in China - 27 Jan 2022
MicroPort® MedBot® recently announced that its Toumai® Laparoscopic Su...MicroPort NeuroTech™ Receives NMPA Marketing Approval for its Diveer® Intracranial Balloon Catheter - 27 Jan 2022
MicroPort NeuroTech™ has received marketing approval from China’s Nati...MicroPort® Orthopedics Receives NMPA Marketing Approval for its Procotyl®-L Acetabular Cup System and Profemur® Preserve Hip Stem - 27 Jan 2022
MicroPort® Orthopedics recently announced that it has received registr...First Patient Enrolled in MicroPort NueroTech™ PROMISE Study for Rebridge® Intracranial Visualized Stent - 27 Jan 2022
MicroPort NeuroTech™ recently announced that it has enrolled the first...